Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
4.970
-0.010 (-0.20%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Serina Therapeutics Employees
As of December 31, 2024, Serina Therapeutics had 13 total employees, including 12 full-time and 1 part-time employees. The number of employees increased by 2 or 18.18% compared to the previous year.
Employees
13
Change (1Y)
2
Growth (1Y)
18.18%
Revenue / Employee
$10,000
Profits / Employee
-$977,538
Market Cap
50.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 2 | 18.18% |
| Dec 31, 2023 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SER News
- 18 days ago - Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson's Disease - GlobeNewsWire
- 19 days ago - Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson's Disease under 505(b)(2) NDA Pathway - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
- 2 months ago - Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD) - GlobeNewsWire
- 2 months ago - Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 2 months ago - Serina Therapeutics Makes Grant to New Employee Under Inducement Plan - GlobeNewsWire
- 3 months ago - Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting - GlobeNewsWire